Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy

被引：12
作者：
Papic, Neven [1 ]
Maric, Lorna Stemberger [1 ,2 ]
Vince, Adriana [1 ,3 ]
机构：
[1] Univ Hosp Infect Dis, Zagreb, Croatia
[2] Univ Zagreb, Sch Dent Med, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
INFECTIOUS DISEASES | 2018年 / 50卷 / 06期
关键词：
RESISTANT ENTEROCOCCI; METRONIDAZOLE; EPIDEMIOLOGY; DISEASE; ADULTS;
D O I：
10.1080/23744235.2018.1425551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：483 / 486
页数：4
相关论文
共 50 条
  • [11] Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure
    Johnson, Steven W.
    Brown, Shannon, V
    Priest, David H.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (05) : 1133 - 1139
  • [12] A Real-World Evaluation of Oral Vancomycin for Severe Clostridium difficile Infection: Implications for Antibiotic Stewardship Programs
    Le, Frank
    Arora, Vaneet
    Shah, Dhara N.
    Salazar, Miguel
    Palmer, Hannah R.
    Garey, Kevin W.
    PHARMACOTHERAPY, 2012, 32 (02): : 129 - 134
  • [13] The effect of concomitant use of systemic antibiotics in patients with Clostridium difficile infection receiving metronidazole therapy
    Jin, S. J.
    Seo, K. H.
    Wi, Y. M.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (05) : 558 - 564
  • [14] Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection
    Bass, S. N.
    Bauer, S. R.
    Neuner, E. A.
    Lam, S. W.
    JOURNAL OF HOSPITAL INFECTION, 2013, 85 (01) : 22 - 27
  • [15] Vaccines in development for the primary prevention of Clostridium difficile infection
    Legenza, Laurel M.
    Barnett, Susanne G.
    Rose, Warren E.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (04) : 547 - 549
  • [16] The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection
    Rokas, Kristina E. E.
    Johnson, James W.
    Beardsley, James R.
    Ohl, Christopher A.
    Luther, Vera P.
    Williamson, John C.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) : 934 - 941
  • [17] Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study
    Gentry, C. A.
    Nguyen, P. K.
    Thind, S.
    Kurdgelashvili, G.
    Skrepnek, G. H.
    Williams, R. J., II
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) : 987 - 993
  • [18] Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis
    Chihara, Shingo
    Shimizu, Riha
    Furukata, Satoshi
    Hoshino, Koichi
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (02) : 149 - 150
  • [19] Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study
    Popovic, Natasa
    Korac, Milos
    Nesic, Zorica
    Milosevic, Branko
    Urosevic, Aleksandar
    Jevtovic, Djordje
    Mitrovic, Nikola
    Markovic, Aleksandar
    Jordovic, Jelena
    Katanic, Natasa
    Barac, Aleksandra
    Milosevic, Ivana
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (04) : 745 - 754
  • [20] Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy
    Tieu, Jennifer D.
    Schmidt, Sarah A.
    Miller, Jamie L.
    Kupiec, Katherine E.
    Skrepnek, Grant H.
    Liu, Connie
    Smith, Winter J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) : 520 - 528
12345